Skip to content

Castle Biosciences CSTL Gross Carrying Amount

Gross Carrying Amount at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Veracyte logo
VeracyteVCYT
GeneDx Holdings logo
GeneDx HoldingsWGS

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's gross carrying amount?
Castle Biosciences (CSTL) reported gross carrying amount of $154.06M in Q1 2026.
How has Castle Biosciences's gross carrying amount changed year-over-year?
Castle Biosciences's gross carrying amount increased by 22.4% year-over-year, from $125.88M to $154.06M.
What is the long-term trend for Castle Biosciences's gross carrying amount?
Over 4 years (2021 to 2025), Castle Biosciences's gross carrying amount has grown at a 14.1% compound annual growth rate (CAGR), from $90.88M to $154.06M.